Navigation Links
Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program
Date:2/20/2008

nable. Investors are cautioned that all such statements involve risks and uncertainties, including without limitation, statements concerning improving our profitability, finding a financial partner for the depression indication, executing our plan to develop reimbursement coverage for depression, transferring the depression indication to a separate entity, maintaining at least a minority interest in such separate entity, seeking appropriate partnership opportunities, improving our cash position, enhancing the value of the company to shareholders, growing the company's business and continuing to strengthen the company's position in the neuromodulation device business sector. Our actual results may differ materially. Important factors that may cause actual results to differ include, but are not limited to: continued market acceptance of VNS Therapy and sales of our product; the development and satisfactory completion of clinical trials and/or market test and/or regulatory approval of VNS Therapy for the treatment of other indications; satisfactory completion of post-market studies required by the U.S. Food and Drug Administration as a condition of approval for the treatment-resistant depression indication; adverse changes in coverage or reimbursement amounts by third-parties; intellectual property protection and potential infringement claims; maintaining compliance with government regulations and obtaining necessary government approvals for new indications; product liability claims and potential litigation; reliance on single suppliers and manufacturers for certain components; the accuracy of management's estimates of future expenses and sales; the results of the previously disclosed governmental inquiries; the potential identification of material weaknesses in our internal controls over financial reporting; risks and costs associated with such governmental inquiries and any litigation relating thereto or to our stock option grants, procedures, and practices (includin
'/>"/>
SOURCE Cyberonics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Cyberonics Licenses Obesity-Related Patents
2. Cyberonics Announces Conference Call to Discuss FY08 Q3 Financial Results
3. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
4. Haemacure Reports Third Quarter 2007 Results
5. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
6. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
7. MDS Reports Third Quarter 2007 Results
8. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
9. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
10. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
11. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... Baltimore, Maryland (PRWEB) March 04, 2015 ... from broccoli, announced today the rebrand of its SGS™ ... deliver at least 13 percent glucoraphanin, which is the ... the market. Brassica’s rebranding initiative includes a new truebroc ... reflect the new look and brand name. , ...
(Date:3/4/2015)... March 04, 2015 Whatever one's feelings about ... it has people talking. Everyone from hard-core fans of the ... next door neighbour who hasn't read even one of the ... according to Erika Korbabicz, the general manager of HUSH, a ... south Edmonton, is a very good thing. , "When the ...
(Date:3/4/2015)... The defibrillators report provides insights into the growth ... the global market is expected to grow at a ... by 2019. It expects the emerging markets to provide ... established players in the market. , According to the ... at the highest CAGR during the next five years. ...
(Date:3/4/2015)... proud to announce a new probiotic lozenge which, in addition ... , Many health experts agree that introducing healthy bacteria ... can cause unwanted infections. While most people produce some level ... help of a probiotic to elevate the most crucial “good” ... S. salivarius M18 & K12 strains of “good” bacteria, the ...
(Date:3/4/2015)... 2015 Follow us on ... growth worldwide, supported by the numerous intraoperative, and ... and single incision surgery will continue to spur ... invasive surgery, driving its adoption among patients and ... site, lower blood loss, shorter hospital stays, faster ...
Breaking Medicine News(10 mins):Health News:Brassica Protection Products Rebrands its SGS™ Brand of Glucoraphanin to truebroc™ 2Health News:Fifty Shades of Grey™ Has Canadians Talking About Sex. 2Health News:Defibrillators Market worth $12.9 Billion by 2019 with Rise in Aging Population - New Research Report by MarketsandMarkets 2Health News:Defibrillators Market worth $12.9 Billion by 2019 with Rise in Aging Population - New Research Report by MarketsandMarkets 3Health News:TheraBreath introduces a new line of probiotic lozenges that strengthen the body’s ability to fight germs 2Health News:Growing Demand for Less Invasive Procedures Drives Growth in the Endoscopy Systems Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Growing Demand for Less Invasive Procedures Drives Growth in the Endoscopy Systems Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Growing Demand for Less Invasive Procedures Drives Growth in the Endoscopy Systems Market, According to a New Report by Global Industry Analysts, Inc. 4
... Equals Two Servings of ... Fruit, ORLANDO, ... to eat and drink healthier, adding Sun Shower(TM) 100%,Nectarine Juices into a diet ... "The wellness benefits of Sun Shower(TM) Nectarine Juices are,tremendous," said Chris New, founder, ...
... Pa., Jan. 7 Parkway Clinical Laboratories, (http://www.parkwayclinical.com ... in Bensalem, Pa., has expanded its,management team by ... Ph.D., as vice president of Operations, Carolyn Bonner ... director of Sales., "We begin the New ...
... on Both Coasts, ARLINGTON HEIGHTS, Ill., Jan. ... procedures differ and they do not,always match that ... by the American Society of Plastic Surgeons (ASPS). ... and Washington, D.C.,(including Baltimore, Md.) were surveyed on ...
... 7 MedPredict Market Research, a,global provider ... published "Thought Leader Insight & Analysis: Obesity,",designed ... and biotech,companies with a stake in the ... measures, obesity in the Western World is ...
... Offers Convenient SYMLIN Administration for Enhanced Glucose ... Control With ... Amylin Pharmaceuticals,Inc. (Nasdaq: AMLN ) announced today the ... devices for administering,SYMLIN(R) (pramlintide acetate) injection. These new pre-filled,pen-injector ...
... release is available in Spanish . , A ... Department of Biochemistry and Molecular Biology at Universitat Autnoma de ... is detected in large quantities only in lung cancers, particularly ... the cancer has not yet developed and lesions are precancerous. ...
Cached Medicine News:Health News:Start Your Day the Sun Shower(TM) Way 2Health News:Parkway Clinical Laboratories Expands Management Team to Support a National Growth Strategy Centered on Oral Fluid Drug Screening 2Health News:ASPS Survey Taps Top Markets for Regional Plastic Surgery Data 2Health News:ASPS Survey Taps Top Markets for Regional Plastic Surgery Data 3Health News:ASPS Survey Taps Top Markets for Regional Plastic Surgery Data 4Health News:Pipeline for New Obesity Therapies is Focus of New Report 2Health News:SYMLIN Pen-Injector Devices Now Available 2Health News:SYMLIN Pen-Injector Devices Now Available 3Health News:SYMLIN Pen-Injector Devices Now Available 4Health News:UAB research could improve the prognosis and treatment of lung cancer 2
(Date:3/4/2015)... , March 4, 2015 Perrigo Company plc (NYSE: ... President and CEO Joseph C. Papa will present ... on Wednesday, March 11, 2015 at the Loews Miami Beach ... can access the presentation webcast at http://perrigo.investorroom.com/events-webcasts . ... remedies in 1887, Perrigo Company plc, headquartered in ...
(Date:3/4/2015)...  ANI Pharmaceuticals, Inc. (NASDAQ: ANIP ) announced ... Conference at the Ritz-Carlton at Laguna Niguel, California ... Arthur S. Przybyl , President and CEO, will give ... of ANI,s website at www.anipharmaceuticals.com . Mr. Przybyl,s presentation ... and available through the link through June 7, 2015. ...
(Date:3/3/2015)... , March 3, 2015  Vermillion, Inc. (NASDAQ: ... disease, today announced management will present at the 27 th ... Ritz-Carlton in Dana Point, California from ... CEO of Vermillion, Valerie Palmieri , will be presenting ... be joined by Eric Schoen , the company,s Vice ...
Breaking Medicine Technology:Perrigo Company To Present At The 2015 Barclays Global Healthcare Conference 2ANI Pharmaceuticals To Present At 27th Annual ROTH Conference 2Vermillion To Present at 27th Annual ROTH Conference on March 9 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: